Reduced-Intensity Chemotherapy with Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study
暂无分享,去创建一个
M. Konopleva | H. Kantarjian | G. Garcia-Manero | Xuelin Huang | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | S. Kornblau | S. O'brien | J. Burger | J. Khoury | N. Pemmaraju | N. Jain | N. Short | J. Jorgensen | W. Wierda | Sa A. Wang | C. Loiselle | Y. Alvarado | C. Rausch | Meagan Rostykus | R. Garris | M. Kwari | J. Jacob | J. Rivera | A. Milton | Rebecca E. Garris